跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
花嘉玲 Kate
助理研究員
國立陽明交通大學
h-index
h10-index
h5-index
185
引文
7
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
184
引文
7
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
54
引文
3
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2011
2024
每年研究成果
概覽
指紋
網路
研究成果
(11)
類似的個人檔案
(6)
指紋
查看啟用 Kate Hua 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Aqueous Humor
100%
Exosomes
78%
Myopia
66%
Hepatocellular Carcinoma Cells
66%
Cell Migration
54%
Exosomal Protein
51%
In Cancer
44%
Hepatocellular Carcinoma
41%
Fusion Gene
37%
Quantitative PCR
35%
Microarray
35%
Adipogenesis
33%
Proteomic Analysis
33%
Stomatin
33%
Epigenomics
33%
Chromosome Breakage
33%
E2F Transcription Factor 1 (E2F1)
33%
Hypomethylating Agents
33%
Cell Characterization
33%
Kuan-Sin-Yin
33%
ERK Pathway
33%
Fatty Acid Uptake
33%
Chemokine (C-C motif) Ligand 2 (CCL2)
33%
Muscle Gene Expression
33%
Cell Mobility
33%
Lipid Droplet Formation
33%
MiR-23a
33%
MicroRNA-23a
33%
Aging
33%
Proteomic Profiling
33%
Cancer Cells
33%
Fibronectin Type III Domain-containing Protein 5 (FNDC5)
33%
Cell Adhesion Molecule 1 (CADM1)
33%
Gastric Cancer Cells
33%
Hepatoma Cells
33%
Traditional Chinese Medicine
33%
Age-related Macular Degeneration
33%
Aged Mice
33%
TIMP-2
33%
Skeletal muscle
33%
Cancer Cell Proliferation
33%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
33%
Expression Profiling
33%
RNA Exosome
33%
Tumorigenesis
30%
MicroRNA
26%
PRKCI
22%
FNDC3B
22%
Homozygous Deletion
22%
Amplicon
22%
Biochemistry, Genetics and Molecular Biology
Humor
100%
Cancer Cell
75%
Gene Expression
66%
Proteomics
66%
Cell Proliferation
58%
Cell Migration
53%
MicroRNA
53%
Carcinogenesis
46%
Liquid Chromatography-Mass Spectrometry
41%
Fusion Gene
37%
Adipogenesis
33%
Human Genome
33%
Chromosome Breakage
33%
Stomatin
33%
Fibronectin Type III Domain
33%
Fatty Acid Transport
33%
Methylation
33%
Cytokine
33%
Transcription Factor E2F1
33%
Skeletal Muscle
33%
Metalloprotease Inhibitor
33%
Lipid Droplet
33%
Oncogene
30%
Tandem Mass Spectrometry
27%
Colony Formation
19%
Adipocyte
16%
Bisulfite
16%
Epigenetics
16%
Vascular Endothelial Growth Factor
16%
Amplicon
16%
Bisulfite Sequencing
16%
Histone
16%
RNA
13%
Muscarinic Acetylcholine Receptor
13%
Lipid Raft
11%
Tumor Suppressor Protein
11%
Low Drug Dose
11%
Transfection
11%
Transcription Factors
11%
Peroxisome Proliferator-Activated Receptor
11%
Bioinformatics
10%
Immunity
8%
SNP Array
8%
Muscle Function
8%
Energy Metabolism
8%
Gene Ontology
8%
Transcription
8%
Rapid Amplification of cDNA Ends
8%
Gene Fusion
8%
High Throughput Sequencing
8%